Recent Updates on Multifunctional Nanomaterials as Antipathogens in Humans and Livestock: Classification, Application, Mode of Action, and Challenges

Molecules. 2023 Nov 20;28(22):7674. doi: 10.3390/molecules28227674.

Abstract

Pathogens cause infections and millions of deaths globally, while antipathogens are drugs or treatments designed to combat them. To date, multifunctional nanomaterials (NMs), such as organic, inorganic, and nanocomposites, have attracted significant attention by transforming antipathogen livelihoods. They are very small in size so can quickly pass through the walls of bacterial, fungal, or parasitic cells and viral particles to perform their antipathogenic activity. They are more reactive and have a high band gap, making them more effective than traditional medications. Moreover, due to some pathogen's resistance to currently available medications, the antipathogen performance of NMs is becoming crucial. Additionally, due to their prospective properties and administration methods, NMs are eventually chosen for cutting-edge applications and therapies, including drug administration and diagnostic tools for antipathogens. Herein, NMs have significant characteristics that can facilitate identifying and eliminating pathogens in real-time. This mini-review analyzes multifunctional NMs as antimicrobial tools and investigates their mode of action. We also discussed the challenges that need to be solved for the utilization of NMs as antipathogens.

Keywords: antipathogen application; challenges; mechanism; multifunctional nanomaterials.

Publication types

  • Review

MeSH terms

  • Animals
  • Anti-Infective Agents* / pharmacology
  • Humans
  • Livestock
  • Nanostructures*
  • Prospective Studies

Substances

  • Anti-Infective Agents

Grants and funding

The authors are grateful for financial support from the National Natural Science Foundation of China (No. 32372948), the Jiangsu Provincial Key Research and Development Program (No. BE2022355), and the China Agriculture Research System of MARA.